key: cord-0690311-hshpw41p
authors: Magdy, Rehab; Kishk, Nirmeen A.; Fouad, Amr M.; Alsayyad, Enas
title: Risk Estimation of SUDEP during COVID-19 Pandemic Era in a Tertiary Referral Center
date: 2021-03-24
journal: Epilepsy Res
DOI: 10.1016/j.eplepsyres.2021.106625
sha: 442d045f385969a2b96c1be10c3fa18218bc4b81
doc_id: 690311
cord_uid: hshpw41p

OBJECTIVE: No data exist regarding the impact of the lockdown due to the COVID-19 pandemic on the risk factors of sudden unexpected death in epilepsy (SUDEP). This study aimed to stratify risk factors of SUDEP in relation to COVID-19 lockdown, among patients with epilepsy (PWE) in Cairo University epilepsy unit (CUEU). Therefore, we can detect risk factors and mitigate such factors in the second wave of the virus. METHODS: an observational, cross-sectional study carried on 340 Egyptian patients with active epilepsy. Individual risk identification and stratification was done by using The SUDEP and seizure Safety Checklist, after which sharing risk knowledge to PWE and their caregivers was undertaken. RESULTS: The mean age of patients was 29.72 ± 12.12. The median of the static factors was 4 (IQR 3-5) whereas, the median of the modifiable factors was 2 (IQR 1-3). Epilepsy emergencies (serial seizures or status epilepticus) were reported in 24.1% of patients, for which non-compliance was the commonest cause, followed by deferral of epilepsy surgery for patients with drug resistant epilepsy (DRE). Stepwise logistic regression analysis showed that use of anxiolytic medications, non-compliance, keeping patients with DRE on dual anti-seizure medications (ASMs), or adding third medication increased the odds of increased seizure frequency by 2.7, 3.5, 16.6 and 6.1 times, respectively. CONCLUSION: Some COVID-19 related issues had influenced the risk of seizure worsening including postponing epilepsy surgery for patients with DRE, non-compliance, and psychiatric comorbidities. Special attention should be paid to these issues to mitigate the risk of SUDEP.

Sudden unexpected death in epilepsy (SUDEP) is the most common cause of epilepsy related deaths. Its incidence varies, it affects 0.09 to 1.2/1000 person-years in general epilepsy population and 9.3/1000 person-years in epilepsy surgery candidates (Keddie et al., 2016; Tomson, Nashef, & Ryvlin, 2008) . Many risk factors are associated with SUDEP. Some are modifiable and others are non-modifiable. Increased seizure frequency especially generalized tonic clonic seizures, nocturnal seizures, polytherapy are among the modifiable risk factors. While male gender, younger age of onset, longer epilepsy duration, intellectual disability are among non-modifiable risk factors (Hesdorffer & Tomson, 2013; Watkins, Shankar, & & Sander, 2018) . Identification of modifiable J o u r n a l P r e -p r o o f risk factors for SUDEP is essential to detect individuals who are at risk. So that risk factors can be mitigated and SUDEP can be prevented. (Whitney & Donner, 2019) Coronavirus disease 2019 is affecting many countries of the world. Africa is the last continent to be affected but it is the most vulnerable. The first case of COVID-19 in Egypt was confirmed on 14th of February, 2020 (Lone & Ahmad, 2020) . Some studies expected the COVID-19 peak in Egypt to be in the middle of June 2020 (Anwar & AbdelHafez, 2020; El Desouky, 2020) .

The lockdown imposed by the Egyptian government due to the pandemic, may impede patients' access to our epilepsy clinic in Qasr Al-Ainy, which is the oldest tertiary center in Middle East region to receive their regular follow up and to dispense anti-seizure medications (ASMs). On the other hand, patients with drug resistant epilepsy (DRE) whose presurgical evaluation was deferred due to the COVID-19 lockdown, present another major problem. Also, stress and anxiety may add to the increased seizure frequency during the pandemic especially in patients with epilepsy (PWE) with premorbid psychiatric disorders (Alkhotani, Siddiqui, Almuntashri, & Baothman, 2020) .

The patients with epilepsy and their families have the right to understand the risks of their condition and to be involved in the decision-making and treatment. According to the 2012 National Institute of Health and Care Excellence (NICE) guidelines, tailored information about SUDEP, the patient's individual SUDEP risk and measures to reduce this risk should be discussed with patient (Excellence, 2012 accessed June 2016 .

The aim of this study was to stratify risk factors of SUDEP among PWE in Cairo University epilepsy unit (CUEU) in relation to COVID-19 lockdown, by using The SUDEP and Seizure J o u r n a l P r e -p r o o f Safety Checklist paving the way for discussing the modifiable factors and future strategies with patients, in order to mitigate such factors in the second wave of the virus.

The current study was an observational, cross-sectional study, conducted on 340 Egyptian patients with active epilepsy, who were currently on ASMs and had one or more seizures in the past year (Zack MM, 2017). The study targeted PWE, of any age and both sexes, who were following up with us in the epilepsy clinic of Cairo University Epilepsy Unit (CUEU) before the emergence of the epidemic in Egypt. The patients were recruited in the period of August 15 to September 15, 2020.

With the emergence of the epidemic in Egypt, the CUEU applied the following strategy: Activating some means of Telemedicine that were appropriate to our patients' capabilities, in the form of J o u r n a l P r e -p r o o f communicating with the epilepsy team via mobile or WhatsApp, although it was of limited use before. Medications were dispensed every two months instead of every month to reduce the crowdedness and overflow in the outpatient clinic during pandemic. We emphasized with the patients, on the importance of compliance to their ASMs in seizure control. For all patients with DRE, epilepsy surgery had been postponed. Patients with DRE either were kept on double ASMs or received a third drug, according to the patient's preference. All included patients in this study were submitted to this strategy.

The SUDEP and seizure Safety Checklist (Shankar et al., 2013) was conducted during face-toface interviews with each patient or caregiver if patients were adolescents or had an intellectual disability. The SUDEP and Seizure Safety Checklist is an evidence-based tool of 19 modifiable and non-modifiable factors. Static factors are male sex, epilepsy duration (15-30 years), unclear treatment history, generalized tonic-clonic seizures, and intellectual disability. Young age (<45 years) represents a moderate risk static while early onset of epilepsy (<15 y) represents the established risk static one. Modifiable factors are increase severity of seizures (serial fits or status epilepticus), three or more ASMs, non-compliance issues, frequents ASMs prescribing changes, sub-therapeutic ASMs level, carbamazepine intake, reported alcohol intake, psychiatric comorbidities, anxiolytic medications and increase seizure frequency. The later represents the established risk modifiable one if increased more than 25%. In case of nocturnal seizures, sleeping in prone position and no night surveillance represent the moderate risk modifiable factors.

After finishing the checklist, sharing risk knowledge to PWE and their caregivers was undertaken including individual risk identification, risk stratification and its modification if possible. At the end of discussion, the patient or the caregiver was asked this question "After the SUDEP J o u r n a l P r e -p r o o f information, please describe any positive, negative consequences or indifference?" Some examples for positive consequences were a patient's promise to adhere to treatment or interact more with the physician through the available telemedicine services. On the other hand, fear or crying expressed negative consequences.

All PWE who visited the epilepsy clinic of CUEU during the recruitment period and fulfilled the eligibility criteria were included in the study (340 patients).

The ethical committee of the Faculty of Medicine, Cairo University, approved the study proposal.

The study design was consistent with the requirements of Revised Helsiniki Declaration of biomedical ethics.

SPSS (statistical package for social sciences) version 18.0 was used for data management and data analysis. Mean ± standard deviation (SD) described quantitative variables and median with interquartile range (IQR) when appropriate (distribution did not follow normality). Number and percentages described qualitative data and Chi-square or / Fisher exact tested proportion independence. Also Chi-square test for Goodness of fit was used to test an observed binomial distribution to an expected one. For comparing mean values of 2 independent groups, parametric and non-parametric t test were used. Stepwise logistic regression analysis was used to detect independent variables of having increase seizure frequency as compared to not having. The J o u r n a l P r e -p r o o f likelihood of increase seizure frequency was expressed as odds ratio (OR) and 95% confidence interval (CI). P value is always 2 tailed and significant at 0.05 level.

The present study included 340 PWE, with mean age of 29.72± 12.12. The majority of patients were females (178, 

The median risk factors of SUDEP was 6 per patient with IQR 4-8. The median of the static factors was 4 with IQR 3-5 whereas, the median of the modifiable factors was 2 with IQR 1-3. Distribution of different static and modifiable risk factors listed in the SUDEP and Seizure Safety Checklist among the study population was shown in Table 1 .

After individual risk stratification by using the SUDEP and Seizure Safety Checklist, the majority of the study population (259, 76.2%) showed positive consequences; while 50 patients (14.7%) had negative consequence and only (31, 9.1%) had indifference.

During the pandemic, 82 PWE (24.1%) of our sample had epilepsy emergencies either in the form of serial fits or status epilepticus (SE), for which non-compliance was accused in the majority of them (65.8%), while deferral of epilepsy surgery for patients with DRE was the cause in 34.2%.

Several factors were significantly associated with increase in seizure frequency (Table 2) .

Stepwise logistic regression analysis was performed for prediction of having increased seizure frequency using the following variables in the model : age, depression, DRE strategy of giving dual therapy, DRE strategy of giving triple therapy, non-compliance, DRE lesional or not, sex, nocturnal seizures, early onset of epilepsy, sub therapeutic ASMs level, and, anxiolytic medications.

Age, DRE strategy of giving dual therapy or giving triple therapy, non-compliance, and anxiolytic medications were retained as independent risk factors associated with increased seizure frequency (Table 3) .

Use of anxiolytic medications, non-compliance, keeping patients with DRE on dual ASMs or adding third medication were associated with increased the odds of increased seizure frequency by 2.7, 3.5, 16.6 and 6.1 times, respectively (Table 3 ).

This is the first study to measure the impact of COVID-19 pandemic era on risk factors of SUDEP.

It is important to identify modifiable factors contributing to the high risk of SUDEP due to this pandemic, so that we can work to minimize them in the second wave of the virus. We totally believe that future changes to improve seizure risk outcomes is a shared responsibility with clinicians and PWE, which was facilitated by using the SUDEP and Seizure Safety Checklist.

Although, the median risk factors of SUDEP was apparently high per patient (6, IQR 4-8), the weight of the static factors (Median 4, IQR 3-5) was higher compared to that of the modifiable factors (Median 2, IQR 1-3).

This study showed that 25.3 % of patients were not compliant. Non-compliance issues may occur because of the difficulty of obtaining medications or lack of motivation associated with underlying psychiatric comorbidities. This can be alleviated during the expected second wave by expanding telemedicine service, purchasing prescription drugs for a longer duration, and special care of PWE with psychiatric comorbidities. However, the use of telemedicine is limited in developing countries, and its expansion is a challenge where the some people's culture lacks the use of technology (Combi, Pozzani, & Pozzi, 2016) . This study revealed that non-compliance was associated with increased the odds of seizure frequency by more than three times.

The most affected group during the epidemic is the DRE group, who were preparing for epilepsy surgery and deferred due to the epidemic circumstances. In this study, the majority of patients with DRE (71.8%) were on three ASMs, although adding third ASM opposes the definition of DRE (Jobst, 2015) . Nevertheless, the strategy of adding a third ASM was associated with increasing the odds of increasing seizure frequency by only 6 times while the odds were increased to 16 times by maintaining the same dual ASMs. For the expected second wave, some bridge therapies that do not necessitate hospitalization must be raised as options for patients with DRE, as ketogenic diet (Williams & Cervenka, 2017) and intermittent fasting (Hartman, Rubenstein, & Kossoff, 2013) .

However, the real risk of proceeding and the real risk of deferral on epilepsy surgery should be considered case by case. Even if these bridge therapies are not implemented, the addition of a third drug will be the best scenario as a temporary solution.

Escalating COVID-19 crises may exacerbate mental stress in PWE with underlying psychiatric comorbidities via exaggerated fear of infection, lifestyle disturbances, economic insecurity, social distance, or changes in medication compliance, all of which may affect the frequency of seizures (Kuroda, 2020) . Indeed, use of anxiolytic medications was associated with increase the likelihood of increasing seizure frequency by 2.7 times during the pandemic. For the expected second wave, collaboration with psychiatric team should be revitalized with proper awareness and delivering correct information to reduce unnecessary anxiety and stress in this vulnerable group.

In this study, the most common reported cause of SE occurrence was the non-compliance (65.8%), while deferral of epilepsy surgery for patients with DRE was the second cause in 34.2%. A previous study conducted in our center 2 years ago, revealed that lesional DRE was the most common cause of SE cases (Alshimaa S. Othman 2020). This confirms that the extent of nonadherence to ASMs among PWE increased during the epidemic period.

Ultimately, the emotional consequences of the patients or their relatives had to be evaluated after educating the patients about SUDEP. However, the positive consequences reported by the majority of our patients (76.2%) are very promising. This reflects patients' willingness to cooperate with us in order to modify the factors that contributed to the increased risk of SUDEP. Patients who have developed panic should be given special psychiatric care, otherwise the study will be counterproductive. For example, some people may decide to discontinue their treatment as long as death awaits them.

The main limitation of this study was its cross-sectional design, assessing the current risk of SUDEP without putting into consideration the baseline risk before the pandemic. Follow up of our patients to assess changes in SUDEP risk during the coming second wave is mandatory. 

The effect of COVID-19 pandemic on seizure control and self-reported stress on patient with epilepsy

Ehab Shaker , Mye A. Basheer , Nelly Alieldin , and Rehab Magdy

Predictors of Outcome in Egyptian Patients with Status Epilepticus: A Prospective Study

Forecasting the Peak of Novel Coronavirus Disease in Egypt Using Current Confirmed Cases and Deaths. medRxiv

Telemedicine for Developing Countries. A Survey and Some Design Issues

Prediction of the Epidemic Peak of Covid19 in Egypt

The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care

Intermittent fasting: a "new" historical strategy for controlling seizures?

Sudden unexpected death in epilepsy. Potential role of antiepileptic drugs

Consensus Over Individualism: Validation of the ILAE Definition for Drug Resistant Epilepsy

Discussing sudden unexpected death in epilepsy: Are we empowering our patients? A questionnaire survey

Mental health considerations for patients with epilepsy during COVID-19 crisis

COVID-19 pandemic -An African perspective

Sudden unexpected death in epilepsy (SUDEP): development of a safety checklist

Sudden unexpected death in epilepsy: current knowledge and future directions

Identifying and mitigating Sudden Unexpected Death in Epilepsy (SUDEP) risk factors

Risk Factors for Sudden Unexpected Death in Epilepsy (SUDEP) and Their Mitigation

The role for ketogenic diets in epilepsy and status epilepticus in adults

Neither of the authors has any conflict of interest to disclose.